Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs NativeMed

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NativeMed head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 329 · Grade C

NativeMed

Visit NativeMed Full brief →

FDA warning letter, June 2026 — issued to NativeMed LLC dba NativeMed. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 62 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make NativeMed a bad call — it's best for readers comparing prepaid compounded injections with monthly renewal who confirm the selected supply and administrative cancellation fee. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
74
Track Record
88
51
CoreAge RxBrief Score 94 · 62NativeMed

Price, coverage & the tracker

CoreAge RxNativeMed
Brief Score94/100 (A)62/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$447 upfront for three months

Advertised equivalent $149/month. Separate monthly choice: $159 first month, then $179; compounded injection and shipping described.

Selected quantity and care inclusions need confirmation. Early refund request requires action within twenty-four hours before shipment and deducts an unspecified administrative fee.

Full price details

Compounded semaglutide injection offered; complete selected-prescription quote unknown; three-month plan $447 upfront ($149/month equivalent), or monthly $179 after $159 first month

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$549 upfront for three months

Advertised equivalent $183/month. Separate monthly choice: $199 first month, then $259; selected prescription and supply require confirmation.

Payments ordinarily nonrefundable. Exact next-renewal cancellation deadline and unused-prepaid calculation unconfirmed; early exception has an unspecified fee.

Full price details

Compounded tirzepatide injection offered; complete selected-prescription quote unknown; three-month plan $549 upfront ($183/month equivalent), or monthly $259 after $199 first month

CoverageUS only; restrictions by state, confirmed at intakeService depends on state/provider availability under the terms; complete current medication-specific state list unconfirmed
Brand-name accessNot confirmedBrand comparisons explain differences from compounds, not an established current branded prescribing program.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

NativeMed: Three-month prepay $447/$549; monthly renewal $179/$259 after $159/$199 first month. Refund request within 24 hours also requires no shipment and deducts an undisclosed administrative fee.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.